PHILADELPHIA and LONDON, June 27 /PRNewswire/ -- Thomson Scientific today announced that Liquent is poised to release its next-generation electronic publishing solution, Liquent InSight(R) Publisher. The solution is set to have a major positive impact on pharmaceutical and biotechnology companies' publishing abilities as they migrate to the eCTD.
Following months of collaboration with the Liquent Customer Advisory Board, and in response to the exacting demands of the life sciences market and its regulatory authorities, InSight Publisher has been developed to appeal to existing Liquent CoreDossier(R) and Liquent EZsubs(R) customers, as well as to entice new customers to the fold. Delegates at the forthcoming DIA 2005 event in Washington, DC will be among the first to preview this new electronic publishing system that is positioned to change the landscape of life sciences publishing processes.
InSight Publisher, which will be generally available in August 2005, delivers unrivalled publishing functionality coupled with an intuitive user interface that will boost the Liquent position as the leader in regulatory solutions for the life sciences sector. In its initial release, InSight Publisher will provide complete eCTD submission publishing and lifecycle management. In subsequent releases, InSight Publisher will expand to also enable creation of paper CTD submissions from an original eCTD as well as complete paper submission publishing capabilities.
"We have just completed our annual Liquent 2005 Regulatory Submissions Trends survey and the decision to launch InSight Publisher couldn't be timelier," said Jim Nichols, Vice President of Product Strategy and Marketing, Liquent. "More than three-quarters of survey respondents stated their plan to migrate to the eCTD, one third of which plan to do so in the next ten to eighteen months. InSight Publisher is perfectly positioned to respond to this planned migration by offering the most modern, comprehensive and intuitive solution to handle these publishing demands."
As part of Liquent's ongoing commitment to the hundreds of life sciences companies that rely on its technologies to control the production and publishing of their electronic documents, Liquent has announced that it is offering InSight Publisher free of any license fee to all existing CoreDossier and EZsubs clients as part of their maintenance agreements. (See customer news release dated 27.06.05 for qualifying details). This decision is fuelled by Liquent's focus on customer service and commitment to providing its customers with a roadmap of electronic publishing solutions that manage their publishing needs both now and in the future.
"The Liquent approach is in line with our expectations and planning," said Gerhard Schlueter, Head of Global Regulatory Operations, Bayer HealthCare's Pharmaceutical Division. "This will enable us to have a smooth transition from EZsubs to InSight Publisher and will support the further eCTD implementation."
InSight Publisher is also offered as an integrated module of Liquent's regulatory product management suite, InSight Manager, thereby boosting its position as the most comprehensive product management lifecycle solution for the life sciences market. InSight Manager Release 2.0 will also be launched at the DIA 2005 event and it boasts extended capabilities including - registration planning & tracking, product detail management, submission planning & tracking and registered document analysis.
InSight Publisher and InSight Manager 2.0 are available for demonstration at the DIA 41st Annual Meeting in Washington, DC on June 26th through 30th. Visit the Liquent booth, number 251.
For more information on the Liquent Regulatory Affairs Trends survey, its findings and how to secure a copy, please contact
About Liquent regulatory solutions
Liquent regulatory solutions provide software, information products, and related services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time. In addition to technology and services, the Liquent IDRAC database service provides the most comprehensive intelligence on the drug and biologics regulatory environment in 38 of the largest markets in the world. As a result, 48 of the top 50 global life sciences companies rely on Liquent regulatory solutions to stay current with the latest intelligence and to provide the technology and services to compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity, all of which contribute to ensuring patients' and physicians' timely access to new drugs. Over the last decade, more than 5,000 regulatory submissions have been produced using Liquent world-class products and expert services. For more information please visit, http://www.liquent.com/.
About The Thomson Corporation
The Thomson Corporation (http://www.thomson.com/), with 2004 revenues of $8.10 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value- added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate e-learning and assessment, scientific research and healthcare. With operational headquarters in Stamford, Conn., Thomson has approximately 40,000 employees and provides services in approximately 130 countries. The Corporation's common shares are listed on the New York and Toronto stock exchanges Toronto.
Thomson Scientific information solutions can be found at http://www.scientific.thomson.com/ and include, ISI Web of Knowledge(SM) - facilitating discovery by offering seamless navigation to high-quality, multidisciplinary journal (Web of Science(R)), patent (Derwent World Patents Index(R)), and Web content, evaluation tools, and bibliographic management products (EndNote(R)); Thomson Pharma(SM) - an integrated information solution for the pharmaceutical and biotechnology markets; Delphion(R) - providing access to full-text patent documents from the world's leading patent authorities; Techstreet - offering a wide variety of engineering codes and standards; BIOSIS Previews(R) - the world's most comprehensive reference database for life science research; and Information Holdings Inc. - a leading provider of intellectual property and regulatory information products and services for professional end users in corporate and legal markets.
© 2005 PR Newswire